Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Application of the modified clavien classification system to 402 cases of holmium laser enucleation of the prostate for benign prostatic hyperplasia.

Choi JI, Moon KY, Yoon JH, Na W, Lee JB.

Korean J Urol. 2014 Mar;55(3):178-81. doi: 10.4111/kju.2014.55.3.178. Epub 2014 Mar 13.

3.

Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).

Elshal AM, Elmansy HM, Elhilali MM.

BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15.

4.
5.

Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 1.

6.

Safety and efficacy using a low-powered holmium laser for enucleation of the prostate (HoLEP): 12-month results from a prospective low-power HoLEP series.

Becker B, Gross AJ, Netsch C.

World J Urol. 2017 Dec 23. doi: 10.1007/s00345-017-2159-5. [Epub ahead of print]

PMID:
29275506
7.

Holmium laser enucleation of the prostate is effective in the treatment of symptomatic benign prostatic hyperplasia of any size including a small prostate.

Lee MH, Yang HJ, Kim DS, Lee CH, Jeon YS.

Korean J Urol. 2014 Nov;55(11):737-41. doi: 10.4111/kju.2014.55.11.737. Epub 2014 Nov 4.

8.

Holmium Laser Enucleation of the Prostate is Safe for Patients Above 80 Years: A Prospective Study.

Piao S, Choo MS, Kim M, Jeon HJ, Oh SJ.

Int Neurourol J. 2016 Jun;20(2):143-50. doi: 10.5213/inj.1630478.239. Epub 2016 Jun 24.

9.

A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy.

Netsch C, Becker B, Tiburtius C, Moritz C, Becci AV, Herrmann TRW, Gross AJ.

World J Urol. 2017 Dec;35(12):1913-1921. doi: 10.1007/s00345-017-2071-z. Epub 2017 Jul 11.

PMID:
28698991
10.
11.
12.

Holmium laser enucleation of prostate for benign prostatic hyperplasia: seoul national university hospital experience.

Bae J, Choo M, Park JH, Oh JK, Paick JS, Oh SJ.

Int Neurourol J. 2011 Mar;15(1):29-34. doi: 10.5213/inj.2011.15.1.29. Epub 2011 Mar 30.

13.

Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis.

Elkoushy MA, Elshal AM, Elhilali MM.

J Endourol. 2015 Jul;29(7):797-804. doi: 10.1089/end.2015.0060. Epub 2015 Apr 2.

PMID:
25705817
14.

Holmium laser enucleation of the prostate: morbidity in a series of 206 patients.

Kuo RL, Paterson RF, Siqueira TM Jr, Watkins SL, Simmons GR, Steele RE, Lingeman JE.

Urology. 2003 Jul;62(1):59-63. Review.

PMID:
12837423
15.

Efficacy and safety of holmium laser enucleation of the prostate for extremely large prostatic adenoma in patients with benign prostatic hyperplasia.

Kim M, Piao S, Lee HE, Kim SH, Oh SJ.

Korean J Urol. 2015 Mar;56(3):218-26. doi: 10.4111/kju.2015.56.3.218. Epub 2015 Mar 3.

16.

Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery.

Jaeger CD, Krambeck AE.

Urology. 2013 May;81(5):1025-9. doi: 10.1016/j.urology.2013.01.019. Epub 2013 Mar 7.

PMID:
23465142
17.

Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.

Elshal AM, Elkoushy MA, Elmansy HM, Sampalis J, Elhilali MM.

J Urol. 2014 Jan;191(1):148-54. doi: 10.1016/j.juro.2013.06.113. Epub 2013 Jul 8.

PMID:
23845460
18.
19.

Day-Case Holmium Laser Enucleation of the Prostate: Prospective Evaluation of 90 Consecutive Cases.

Comat V, Marquette T, Sutter W, Bernhard JC, Pasticier G, Capon G, Bensadoun H, Ferrière JM, Robert G.

J Endourol. 2017 Oct;31(10):1056-1061. doi: 10.1089/end.2017.0196. Epub 2017 Sep 28.

PMID:
28830227
20.

Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia.

Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, Valenti S, Vavassori I, Rigatti P.

J Urol. 2008 May;179(5 Suppl):S87-90. doi: 10.1016/j.juro.2008.03.143.

PMID:
18405765

Supplemental Content

Support Center